The Valley Desk

ArticleIntestinal researchPublished

Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the Phase 3 GRAVITI study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Intestinal research
Published
Subject terms
Asia; Clinical Trials; Crohn Disease; Guselkumab
PubMed ID
41674029
Added to directory
Source checked

Report a correction or request removal